KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

ARCADIA trials: Can nemolizumab be a valid alternative to the therapies currently available?

Maddalena Napolitano, Cataldo Patruno

Med 5(11) 1340-1341

PMID39520977
PMCID-
DOI10.1016/j.medj.2024.09.008
发表日期2024-11-09
摘要

摘要

ARCADIA 1 and ARCADIA 2 were two randomized, placebo-controlled phase 3 trials showing the effectiveness of nemolizumab with concomitant use of low-to-medium potency topical corticosteroids, and/or with or without topical calcineurin inhibitors, in adults and adolescents with moderate-to-severe atopic dermatitis. Coprimary endpoints were met in the nemolizumab plus background therapy groups in both trials, with significant differences versus placebo.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。